Evidence map›Paper›PMID 39655330›Full record

ArticlePeerJ2024

Hana Svozilova, Lucy Vojtova, Jana Matulova, Jana Bruknerova, Veronika Polakova, Lenka Radova, Michael Doubek, Karla Plevova, Sarka Pospisilova

Abstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hana SvozilovaCenter of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-0025-4364
Lucy VojtovaAdvanced Biomaterials, Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Jana MatulovaAdvanced Biomaterials, Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.
Jana BruknerovaCenter of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Veronika PolakovaAdvanced Biomaterials, Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic.ORCID 0009-0001-0919-5313
Lenka RadovaCenter of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0001-8103-148X
Michael DoubekCenter of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-1269-6282
Karla PlevovaCenter of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-6148-8877
Sarka PospisilovaCenter of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0001-7136-2680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic lymphocytic leukemia (CLL) is a common adult leukemia characterized by the accumulation of neoplastic mature B cells in blood, bone marrow, lymph nodes, and spleen. The disease biology remains unresolved in many aspects, including the processes underlying the disease progression and relapses. However, studying CLL Methods: In our study, we investigated the behavior of CLL cells in two types of material: (i) solid porous collagen scaffolds and (ii) gel composed of carboxymethyl cellulose and polyethylene glycol (CMC-PEG). We studied CLL cells' distribution, morphology, and viability in these materials by a transmitted-light and confocal microscopy. We also measured the metabolic activity of cultured cells. Additionally, the expression levels of Results: Both materials were biocompatible, translucent, and permeable, as assessed by metabolic assays, cell staining, and microscopy. While collagen scaffolds featured easy manipulation, washability, transferability, and biodegradability, CMC-PEG was advantageous for its easy preparation process and low variability in the number of accommodated cells. Both materials promoted cell-to-cell and cell-to-matrix interactions due to the scaffold structure and generation of cell aggregates. The metabolic activity of CLL cells cultured in CMC-PEG gel was similar to or higher than in conventional culture. Compared to the conventional culture, there was (i) a lower expression of

Indexed as

Carboxymethylcellulose SodiumCollagenLeukemia, Lymphocytic, Chronic, B-CellPolyethylene GlycolsTissue ScaffoldsCell Culture TechniquesCell Culture Techniques, Three DimensionalCell SurvivalGelsHumansReceptors, CXCR4Carboxymethylcellulose SodiumCollagenCXCR4 protein, humanGelsPolyethylene GlycolsReceptors, CXCR43D cultureCarboxymethyl celluloseChronic lymphocytic leukemiaCLLCMCCollagenGelPEGPolyethylene glycolScaffolds

Identifiers

PMID39655330
PMCPMC11627079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.